Abstract
Overview
Introduction
Datamonitor estimates that there are over 11 million atrial fibrillation
patients in the seven major markets. Despite high unmet needs and limitations
of all the current treatment options, achievement of regulatory approval is
becoming increasingly difficult. This means that a very limited number of
novel treatments are expected to be introduced in the near future.
Scope
- Review of the available epidemiology data to assess the patient population
of atrial fibrillation and to segment the patient population by type
- Outline of the existing therapy options and current prescribing trends
- Assessment of the current status of the rhythm versus rate control debate
and the determining factors for each type of treatment strategy
- Evaluation of the current usage of cardiac rhythm devices and ablation
techniques in order to determine their future role in AF management
Report Highlights
The rapid increase in atrial fibrillation prevalence is driven by a number of
factors, namely ageing population, the obesity epidemic, better prevention of
strokes, and better survival of patients with cardiac disease.
There are numerous unmet needs associated with every treatment option
available. The main unmet needs of pharmacological therapy are insufficient
efficacy and poor safety. Non-pharmacological therapy has severe limitations,
among them the cost of the procedures and the fact that a limited number of
patients are eligible for it.
Despite the desperate need for a new efficacious and safe antiarrhythmic, no
new drug that would significantly impact atrial fibrillation management is
going to appear in the nearest future.
Reasons to Purchase
- Target physicians more effectively, through an understanding of treatment
options and prescription choices
- Assess the potential of each treatment option in the management of atrial
fibrillation and understand the dynamics of the market
- Recognize lucrative target populations, in terms of unmet need and patient
potential, in order to successfully position developmental products